Lon Trx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lon trx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lon Trx Today - Breaking & Trending Today
Shares of Tissue Regenix Group plc (LON:TRX – Get Free Report) hit a new 52-week high during trading on Wednesday . The stock traded as high as GBX 67 ($0.84) and last traded at GBX 65.50 ($0.82), with a volume of 99614 shares changing hands. The stock had previously closed at GBX 63 ($0.79). Tissue […] ....
Tissue Regenix Group plc (LON:TRX – Get Rating) insider Daniel Lee acquired 500,000 shares of the stock in a transaction dated Tuesday, April 4th. The stock was bought at an average cost of GBX 1 ($0.01) per share, with a total value of £5,000 ($6,209.64). Tissue Regenix Group Price Performance Shares of TRX stock opened […] ....
Tissue Regenix Group has evolved from an R&D organisation to now focus on commercialisation Tissue Regenix Group PLC s (LON:TRX) CEO Danny Lee and CFO David Cocke about their final results for the year which ended 31 December 2020. The firm is now confident in its prospects once the COVID-19 pandemic has subsided and healthcare procedures return to a normalised level. The represent their move from an R&D organisation to now focus on commercialisation, there have been a few changes to the board which Lee talks through and explains their new strategy as a company. Highlights include, entering the UK and specific EU markets with OrthoPure XT and established white label manufacturing capabilities with a large global partner. ....
Tissue Regenix confident on post-COVID-19 prospects The capacity expansion programme will alleviate the supply issues that have previously hindered growth and will provide a step-change in the business trajectory, the firm said Tissue Regenix Group PLC (LON:TRX) said it is confident in its prospects once the Coronavirus (COVID-19) pandemic subsides and healthcare procedures return to a normalised level. The medical technology company has entered the UK and specific EU markets with OrthoPure XT and established white label manufacturing capabilities with a large global partner. The capacity expansion programme will alleviate the supply issues that have previously hindered growth and will provide a step-change in the business trajectory, as the firm secures additional distribution contracts and increases its geographic outreach. ....